Article
Case Report: Methotrexate and hydroxychloroquine in combination for the treatment of NOD2-mutation-associated Blau syndrome.
Frontiers in immunology - 1 Jan 2023
Jensen Mary Ellen, Harrell Katelin, McBride Jeffrey D
Abstract excerpt
Mutations in nucleotide binding oligomerization domain containing 2 receptor (NOD2) are associated with Blau syndrome (also known as early-onset sarcoidosis)-a rare autosomal dominant, chronic granulomatous disease that typically presents before 5 years of age. Blau syndrome is characterized by the clinical triad of arthritis, granulomatous dermatitis, and recurrent uveitis. Here, we report a case of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
